In March 2025, the company introduced new options for just a immediate-to-purchaser offering of its Wegovy weight loss drug. The company set up a whole new pharmacy, named NovoCare, which would charge clients $499 monthly for use of the drug, fewer than 50 percent the price of the drug by way of other pharmaceutical distribution networks.[53]Other